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Vanadyl sulfate (VS) is an ingredient in some food supplements and experimental drugs. This study 
was designed to assay the effects of VS on biomarkers of oxidative stress and inflammation in renal 
tissue of rats with diabetes type 2. 30 male Wistar rats were divided into three equal groups as follow: 
non-diabetics, non-treated diabetics and VS-treated diabetics. Diabetes type 2 has been induced 
through high fat diet and fructose in the animals. Diabetic rats were treated with 25 mg/kgBW of VS 
in water for 12 weeks. At the end of study, glucose and insulin were measured using commercially 
available kits in serum and biomarkers of oxidative stress and inflammation in renal homogenates of 
animals were measured by related methods. Compared to controls, glucose and insulin were increased 
significantly in non-treated diabetic rats (p-value <0.05) that showed the induction of diabetes type 
2 in rats. The results showed that in VS-treated diabetic rats compared to the non-treated diabetic 
group, vanadyl sulfate significantly reduced the glucose and insulin secretion and changed renal 
inflammatory and oxidative markers, except protein carbonyl so that we couldn’t find any significant 
changes. Our study showed that vanadyl supplementation had positive effects on oxidative stress and 
inflammation biomarkers in kidney of diabetic rats.
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INTRODUCTION
Hyperglycemia can lead to diabetic problems and 
their socio-economic burden. Various tissues which 
have been exposed to high concentration of glucose may 
lead to changes in cell signaling, increment of oxidizing 
species or significant reduction in antioxidant capacity. 
Also, hyperglycemia has critical role in Advanced 
Glycation End products (AGEs) formation, as well as, 
secretion of the pro-inflammatory cytokines and cellular 
death (Volpe et al., 2018). Diabetic Kidney Disease 
(DKD) is one of the most common complications of 
diabetes, and its severity has increased throughout the 
world over the last decade due to the growing trend of 
diabetes, as it is becoming a major cause of death and 
mortality (Li, Ma, 2017; Liang, Cai, Chen, 2017). It 
has been documented that trace elements are required 
for proper function of metabolic pathways (Panchal, 
Wanyonyi, Brown, 2017; Mirhashemi, Aarabi, 2011). 
Vanadium, the 3d transition metal, has been considered 
as micro supplements for various biological functions 
in humans (Petanidis et al., 2013; Pessoa et al., 2015; 
Levina, Lay, 2017). Main attention to vanadium has 
focused on anti-diabetic effects but shifted to anti-cancer 
and anti-parasitic drugs (Levina, Lay, 2017; Kioseoglou 
et al., 2015). Vanadyl sulfate has been used in humans 
in the form of insulin-mimetic salt and thus controls 
both DM type 1 and type 2. Vanadyl sulfate protects 
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from beta cells of Langerhans, and therefore provides 
insulin production and secretion that can improve 
blood glucose levels. (Dabros et al., 2004; Ahmadi et 
al., 2010; El-Shenawy, Refat, Fakihi, 2013) (1-3). Due 
to the rising occurrence of DKD, multiform study 
aimed at aborting and remedy is one of the universal 
priorities for researches. To the best of our facts, this 
is among the first studies to evaluate vanadyl sulfate 
on biomarkers of oxidative stress and inflammation in 
kidney of diabetic rats. 
MATERIAL AND METHODS
All chemicals used in this study were purchased 
from Sigma-Aldrich Corporation.
Experimental animals
Healthy male Wistar rats, weighting about 180-
210 g, were prepared from Experimental Animal 
Centre of Kashan University of Medical Sciences, 
and kept at standard conditions 22–24 ° C, 40–60% 
relative humidity and 12h light–dark cycle and fed with 
standard rat food and water ad libitum. The animals 
were protected in agreement with the ethics of care and 
use of experimental animals. The study protocol was 
permitted by the ethics committee of Kashan University 
of Medical Sciences (IR.KAUMS.REC.1395.161).
Induction of diabetes type 2 in rats 
A typical diet of high fat (including 400 grams 
of sheep fat, 200 grams of sucrose, 18 egg yolks and 5 
egg whites and 400 grams of rat chow, well combined 
and homogenized) and high fructose (including 25% 
fructose in drinking water) (HFFD: high fat and high 
fructose diet) was used for 12 weeks in order to generate 
diabetes type 2 model.
Studied groups design
30 rats were randomly divided into 3 equal groups 
as follows. The first group was normal rats that received 
standard rat chow and water without any HFFD/
VS, and considered as control group. The 2nd group 
received HFFD without any treatment (non-treated 
diabetic group) and the 3rd group, received HFFD 
and 25 mg/kgBW vanadyl sulfate (diabetic treated 
with VS25). 
Preparation of sera and kidney homogenate 
After 12 weeks, at the end of their treatment 
periods, the animals were weighed and anesthetized 
using ether and killed by decapitation. Blood samples 
were collected; sera were separated from blood cells by 
centrifugation (Hettich D-78532, Tuttlingen, Germany) 
at 3000 rpm for 15 min, and stored at -80oC until the 
time of analysis. The kidneys were washed with cold 
saline (4 °C) and crushed into smaller pieces on ice, 
homogenized (10% W/V) with phosphate buffer with 
0.1 molar and then centrifuged at 3000 g for 10 minutes 
at 4 °C. The supernatant solution was separated from 
the precipitate and used for measuring the parameters 
(Mirhashemi et al., 2009).
Glucose and insulin assay
Fasting blood glucose level, was determined in 
serum using commercially available kit (Pars Azmun, 
Tehran, Iran) by Mindray auto analyzer. Insulin level 
was quantified by ELISA method using kit of DiaMetra 
Company (Spello, Perugia, Italy). 
Renal tissue oxidative biomarkers assay
Renal Protein Carbonyl (PC) and Malondialdehyde 
(MDA) were measured by colorimetric method using 
cayman chemical (USA) and Zellbio GmbH (Germany) 
commercially available kit with inter- and intra-
assay CVs of lower than 5%, respectively. Superoxide 
Dismutase (SOD) activity was measured using Zellbio 
(Germany) company kit, too.
Inflammatory biomarkers assay
Renal tissue IL-1 and IL-10 concentrations 
were determined using ELISA kit (IBL International 
Company, Germany) with inter- and intra-assay CVs of 
7.5 and 9.1%, respectively. 
Statistical analysis
Data Analysis was performed using the statistical 
package for social science version 23 (SPSS Inc., Chicago, 
Illinois, USA). We conducted the Kolmogrov-Smirnov 
test to evaluate the normality of distribution of variables. 
Significance of differences was determined by ANOVA 
and posthoc Tukey’s test. Results were presented as the 
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Mean ± SEM and statistically determined significant at 
p ≤ 0.05.
RESULTS 
Effect of vanadyl sulfate on glucose, insulin 
and HOMA-IR of studied groups
As it has been shown in Table I, there were 
statistically significant increase (p-value < 0.001) in 
glucose, insulin and HOMA-IR levels in 2nd group 
compared to controls (88.51%, 81.6% and 185.3% 
enhancements, respectively). Treatment with vanadyl 
sulfate resulted in a significant decrease in glucose, 
insulin and HOMA-IR levels in the 3rd group compared 
to the 2nd group by 49.21% (p-value < 0.001), 17.55% 
(p-value=0.012) and 31.9% (p-value = 0.002), 
respectively (Table I).
TABLE I - Effects of HFFD and vanadyl sulfate on fasting 
blood glucose, Insulin and HOMA-IR in experimental groups
Groups Glucose (mg/dL) Insulin(μIU/mL) HOMA-IR
Control 110.91 ± 7.41 1.26 ± 0.04 0.34 ± 0.04
Diabetics 209.08 ± 11.60* 1.88 ± 0.11* 0.97 ± 0.07*
VS25 171.5 ± 9.46* 1.55 ± 0.07* 0.66 ± 0.05*
All groups were fed with HFFD except controls, for 12 weeks.
Treated groups received 25 mg/kg b.w. of vanadyl sulfate 
(VS25) in addition to HFFD for the same time
Data have been shown as Mean ±SEM, n=10.
*Indicated significant variations (p<0.05)
Effects of VS-treatment on oxidative 
stress biomarkers of renal tissue
According to table II and respect to control group, 
oxidative biomarkers including MDA and PC were 
statistically increased significant by 31.51% and 18.12% 
(p-value < 0.001) but SOD activity was decreased by 
27.59% (p-value < 0.001) in the 2nd group. Vanadyl 
sulfate reduced MDA and PC in the 3rd (5.14% & 
5.23%, respectively) group compared to the 2nd group, 
but these changes were statistically significant only for 
MDA (p-value = 0.029) not for PC (p-value = 0.28). Our 
results also showed that SOD activity was significantly 
increased by vanadyl sulfate in VS-treated group by 
114.29% (p-value < 0.001).
TABLE II - Effects of HFFD and vanadyl sulfate on oxidative 
stress biomarkers in kidney of experimental groups
Groups SOD (iU/mL) MDA (μmol/L) PC (nmol/mg)
Control 0.29 ± 0.01 6.82 ± 0.07 2.35 ± 0.09
Diabetics 0.21 ± 0.02* 8.94 ± 0.11* 2.87 ± 0.06*
VS25 0.45 ± 0.01* 8.48 ± 0.15* 2.72 ± 0.04
All groups were fed with HFFD except controls, for 12 
weeks.
Treated groups received 25 mg/kg b.w. of vanadyl sulfate 
(VS25) in addition to HFFD for the same time.
Data have been shown as Mean ±SEM, n=10.
*Indicated significant variations (p<0.05)
Effects of treatment with vanadyl sulfate 
on renal inflammatory markers
Compared to control group, high fat and fructose 
diets led to an increase in IL-1 by 421.95% (p-value 
< 0.001) and a decrease in IL-10 by 41.3% (p-value < 
0.001) in diabetic group. A significant (p-value < 0.001) 
reduction in IL-1 (21.18%) and increment in IL-10 
(42.23%) were observed in VS-treated diabetic group 
compared to diabetics (Table III).
TABLE III - Effects of HFFD and vanadyl sulfate on 
inflammatory biomarkers in kidney of experimental groups
Groups IL-1 (pg/mL) IL-10 (pg/mL)
Control 1.23 ± 0.07 3.51 ± 0.06
Diabetics 6.42 ± 0.08* 2.06 ± 0.04*
VS25 5.06 ± 0.07* 2.93 ± 0.04*
All groups were fed with HFFD except controls, for 12 weeks.
Treated groups received 25 mg/kg b.w. of vanadyl sulfate 
(VS25) in addition to HFFD for the same time
Data have been shown as Mean±SEM, n=10.
*Indicated significant variations (p<0.05)
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DISCUSSION
DKD has been considered as one of the most current 
complication of diabetes and clarified an important 
factor for death and mortality (Zac-Varghese, Winocour, 
2018; Mirhashemi et al., 2016). It has been documented 
that after developing to renal failure, over 70% of DKD 
patients will die within five years (Zarqami et al., 2018), 
so new treatments for slowing down this progression are 
an urgent need that should be taken seriously. According 
to our knowledge, the present study was one of the first 
studies that evaluated the result of vanadyl sulfate on 
inflammatory and oxidative stress parameters in kidney 
of diabetes type 2 models. The first series of results 
showed that compared to controls, glucose and insulin 
were increased significantly in non-treated diabetic rats 
(p-value < 0.001) that showed the induction of diabetes 
type 2 in rats. Further, the results of vanadyl effects on 
these two items showed that vanadyl sulfate significantly 
reduced glucose and insulin secretion. In agreement with 
our study, Zarghami and colleges showed that vanadyl 
sulfate supplements may lead to glucose consumption 
improvement and feed efficiency (Zarqami et al., 2018). 
In kidney tissue of VS-treated rats, biomarkers of 
inflammations and oxidative stress were significantly 
improved, except for the amount of PC that did not 
change statistically. Oxidative stress and inflammation 
have been associated with the pathophysiology of 
diabetic nephropathy (Breyer, Kretzler, 2018; Sun et al., 
2013). Studies about the experimental animal models 
of diabetes strongly implicated oxidant species as a 
major determinant in the pathophysiology of diabetic 
kidney disease (Breyer, Kretzler, 2018). In recent years, 
vanadium compounds have become important for a 
wide range of diseases and its interaction with cytokine 
interleukins has been shown (Lin et al., 2018; Sagoo, 
Gnudi, 2018). Using insulin signaling regulation, Liu and 
colleagues introduced a new complex of vanadium that 
resulted in improved performance of diabetic kidney rats. 
(Tsave et al., 2016). Other authors have also described 
new findings from various studies about the complex 
effects of insulin-mimetic vanadium in diabetic rodents 
(Pelletier et al., 2016; Liu et al., 2014; Jiang et al., 2016). 
Our study had some limitations. The main limitation 
of our study was lack of measuring the serum levels of 
vanadyl sulfate in animals due to financial constraints. 
Indeed, given the limited financial resource available for 
these projects, we did not evaluate some of the markers. 
Therefore, measurement of inflammatory cytokines and 
biomarkers of oxidative stress after intervention were 
reasonable in forthcoming studies. It may be concluded 
that vanadyl sulfate should be a necessary and beneficial 
molecule for the development of the therapeutic agents 
for the improvement of oxidative and inflammatory 
biomarkers in diabetic kidneys. Undoubtedly, further 
studies are needed to reveal the potential and/or possible 
toxicity of this compound in long-term use.
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